The state of Odisha marked a significant milestone in its healthcare and life sciences journey during the recently concluded ‘Utkarsh Odisha: Make-in-Odisha Conclave 2025’, attracting a whopping ₹4,349 crore in investment proposals. The event witnessed a strong response from industry leaders in the healthcare, pharmaceutical, and biotechnology sectors, signaling a transformative shift in the state’s developmental priorities.
Among the standout investment intents received:
- Indo European Heart Hospital and Research Institute Pvt Ltd has pledged ₹1,200 crore towards establishing advanced cardiac care and research facilities.
- SUM Health Care Services plans to invest ₹1,000 crore to establish 50-bed multi-speciality hospitals in every district, a game-changing move toward equitable healthcare access.
- Indo European Research and Healthcare Pvt Ltd has proposed an investment of ₹600 crore, focusing on integrated research and healthcare delivery.
- Vikash Residential Institutions Pvt Ltd, known for its footprint in education, is entering the healthcare sector with a proposed ₹544 crore investment.
- J-VPD Diagnostics Pvt Ltd has committed ₹500 crore to set up diagnostic and pathology labs, aimed at improving early disease detection and specialized testing.
Speaking at the conclave, senior government officials emphasized the state’s commitment to facilitating ease of doing business and fast-tracking clearances for high-impact projects :
“These investments reflect the trust that industry leaders have in Odisha’s vision for a healthier future. We are laying the groundwork for a robust ecosystem that supports innovation, accessibility, and inclusive growth,” said a spokesperson for the Department of Health and Family Welfare.
